Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cygnus GlucoWatch Biographer For Children To Launch In September

This article was originally published in The Gray Sheet

Executive Summary

Cygnus plans to offer a pediatric version of its GlucoWatch Biographer for about $700 when shipments begin in late September

You may also be interested in...



One-Stop Shopping Governs Diabetes Management Market Consolidation

Roche's Disetronic acquisition likely will increase the value of remaining smaller diabetes management companies as the industry trends toward consolidation

One-Stop Shopping Governs Diabetes Management Market Consolidation

Roche's Disetronic acquisition likely will increase the value of remaining smaller diabetes management companies as the industry trends toward consolidation

Abbott Capitulates In Continuous Glucose Deal: Can SpectRx Go It Alone?

SpectRx likely will have to find another development partner for FDA pivotal studies of its consumer continuous glucose monitoring device after initiating termination of a joint R&D and license agreement with Abbott Laboratories Jan. 7

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017083

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel